2023-06-14 05:31:02
“With nearly 60,000 new cases and 12,000 deaths per year, breast cancer is the most common cancer in women in France and the leading cause of cancer death,” says Public Health France. Recalling at the same time that “the national organized screening program for breast cancer invites every two years women aged 50 to 74 to carry out a mammography screening, supplemented by a clinical breast examination (observation and palpation). »
So much for the theory. Because in fact, the latest figures published show a participation rate of only 47.7% over the period 2021-2022. In detail, during the year 2022, 44.9% of the women concerned actually had a mammogram (compared to 50.6% in 2021). “Yet by participating in organized screening, this makes it possible to detect a possible anomaly or cancer at an early stage and thus increase the chances of recovery”, adds Public Health France.
How can this drop be explained?
For the health authorities, participation was directly impacted by Covid-19 and the various confinements. And for Public Health France, “it will probably take a few years for the consequences of the disruptions due to covid-19 to subside, while the gradual decline in the offer in senology (medical specialty devoted to breast pathologies, editor’s note) involved already lengthening the time between two screenings. »
Note: over the 2021-2022 period, participation at regional level varies from 21.2% in Guyana to 55.3% in Pays de la Loire, the region with the highest rate. Very low participation is observed in Ile-de-France, in the South-East and in Corsica.
1686724705
#Breast #cancer #women #participate #screening #Health #News